Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant chemotherapy in operable breast cancer.
Scholl SM, Asselain B, Palangie T, Dorval T, Jouve M, Garcia Giralt E, Vilcoq J, Durand JC, Pouillart P. Scholl SM, et al. Among authors: asselain b. Eur J Cancer. 1991;27(12):1668-71. doi: 10.1016/0277-5379(91)90442-g. Eur J Cancer. 1991. PMID: 1782080 Clinical Trial.
Contralateral breast cancer: annual incidence and risk parameters.
Broët P, de la Rochefordière A, Scholl SM, Fourquet A, Mosseri V, Durand JC, Pouillart P, Asselain B. Broët P, et al. Among authors: asselain b. J Clin Oncol. 1995 Jul;13(7):1578-83. doi: 10.1200/JCO.1995.13.7.1578. J Clin Oncol. 1995. PMID: 7602346
Prognostic factors in inflammatory breast cancer and therapeutic implications.
Palangie T, Mosseri V, Mihura J, Campana F, Beuzeboc P, Dorval T, Garcia-Giralt E, Jouve M, Scholl S, Asselain B, et al. Palangie T, et al. Among authors: asselain b. Eur J Cancer. 1994;30A(7):921-7. doi: 10.1016/0959-8049(94)90115-5. Eur J Cancer. 1994. PMID: 7946584 Clinical Trial.
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6.
Scholl SM, Fourquet A, Asselain B, Pierga JY, Vilcoq JR, Durand JC, Dorval T, Palangié T, Jouve M, Beuzeboc P, et al. Scholl SM, et al. Among authors: asselain b. Eur J Cancer. 1994;30A(5):645-52. doi: 10.1016/0959-8049(94)90537-1. Eur J Cancer. 1994. PMID: 8080680 Clinical Trial.
Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases.
de la Rochefordiere A, Asselain B, Scholl S, Campana F, Ucla L, Vilcoq JR, Durand JC, Pouillart P, Fourquet A. de la Rochefordiere A, et al. Among authors: asselain b. Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):35-41. doi: 10.1016/0360-3016(94)90516-9. Int J Radiat Oncol Biol Phys. 1994. PMID: 8083126
Age as prognostic factor in premenopausal breast carcinoma.
de la Rochefordiere A, Asselain B, Campana F, Scholl SM, Fenton J, Vilcoq JR, Durand JC, Pouillart P, Magdelenat H, Fourquet A. de la Rochefordiere A, et al. Among authors: asselain b. Lancet. 1993 Apr 24;341(8852):1039-43. doi: 10.1016/0140-6736(93)92407-k. Lancet. 1993. PMID: 8096955
Breast tumour response to primary chemotherapy predicts local and distant control as well as survival.
Scholl SM, Pierga JY, Asselain B, Beuzeboc P, Dorval T, Garcia-Giralt E, Jouve M, Palangié T, Remvikos Y, Durand JC, et al. Scholl SM, et al. Among authors: asselain b. Eur J Cancer. 1995 Nov;31A(12):1969-75. doi: 10.1016/0959-8049(95)00454-8. Eur J Cancer. 1995. PMID: 8562150 Clinical Trial.
The purpose of the present paper was to evaluate correlations between clinical response to chemotherapy and outcome in a subgroup analysis of premenopausal patients with tumours considered too large for breast conserving surgery, treated with primary chemotherapy (n = 200) from a …
The purpose of the present paper was to evaluate correlations between clinical response to chemotherapy and outcome in a subgroup analysis o …
384 results